CClinicalTrials.gg
CompletedNCT03179982Updated Jun 24, 2025Results posted

Integrated Prevention of HIV Risk and Intimate Partner Violence Among Adolescents in South Africa

An interventional study of Safe South Africa in Sexual Behavior and Intimate Partner Violence, sponsored by Brown University. Completed at 1 site in South Africa. Open to male participants aged 15 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-24.

Sponsored by Brown University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
15 Years to 17 Years
Sex
Male
01

Study summary

The purpose of this study is to test the feasibility and acceptability of Safe South Africa, an integrated intervention for preventing HIV and Intimate Partner Violence perpetration for male adolescents 15-17 years of age.

Read the detailed description

This study will investigate the acceptability and feasibility of Safe South Africa, an integrated intervention to prevent adolescent behavioral risk for human immunodeficiency virus (HIV) and perpetration of intimate partner violence (IPV). Safe South Africa is a theory-driven, developmentally-tailored and gender-specific intervention designed for male adolescents 15-17 years of age. The research will be conducted in South Africa, a country with the largest HIV epidemic and some of the highest rates of IPV perpetration in the world. Preventive interventions are urgently needed during adolescence when risk for human immunodeficiency virus (HIV) and intimate partner violence (IPV) increases exponentially. Yet, few behavioral interventions integrate HIV-IPV prevention and are tailored for the unique age and developmental needs of adolescents. We will investigate the acceptability and feasibility of Safe South Africa with three study aims: (1) a development aim - this aim will result in the creation of Safe South Africa, an integrated male adolescent preventive intervention for HIV risk behavior and IPV perpetration; (2) an acceptability aim - this aim will consist of an evaluation of the social ecology of HIV and IPV risk with a survey of N=100 of adolescents, and a test of the acceptability of Safe South Africa through an open pilot trial with N=20 male adolescents; and (3) a feasibility aim - this aim will consist of a randomized controlled pilot trial with 1- and 6-month follow-up in a sample of N=60 male adolescents to assess the feasibility and acceptability for a future fully powered randomized controlled trial to evaluate efficacy of the intervention.

02

Conditions studied

  • Sexual Behavior
  • Intimate Partner Violence

Browse trials for

03

Who can participate

Ages eligible
15 Years to 17 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male adolescent
  • 15-17 years of age, inclusive of 15 and 17

Exclusion criteria

Exclusion Criteria:

  • parent/guardian does not provide consent
  • adolescent does not provide assent
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Intervention

    Male adolescents (15-17 years) will be randomly allocated to an intervention arm based on permuted blocked randomization. The intervention arm will receive the HIV-IPV intervention called Safe South Africa. Safe South Africa is a group-based, facilitated behavioral intervention for prevention of HIV risk and IPV perpetration specifically tailored for male adolescents. The behavioral intervention is comprised of 2-hour sessions, held once a week for a total of two weeks.

    Behavioral: Safe South Africa

  • No intervention
    Control

    Male adolescents (15-17 years) will be randomly allocated to a control arm based on permuted blocked randomization. The control arm will consist of ordinary usual care. The ordinary usual care condition will consist of a packet of existing available brochures on HIV and other sexually transmitted diseases including testing, prevention, and treatment; IPV prevention and intervention; and places to access prevention, care, and support for these outcomes and related health outcomes.

Interventions

  • BehavioralSafe South Africa

    Core components of the Safe South Africa intervention include the following: * Theory driven, best-evidence intervention approaches to adolescent HIV prevention * Linkages between HIV and IPV * Victim Empathy * Healthy Norms Regarding Masculinity * Bystander Intervention Skills

05

What researchers measure

Primary outcomes

  1. Number of Participants With Satisfaction With Intervention Content

    Satisfaction with intervention content is based off of a measure called the Client Satisfaction Questionnaire developed by Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: Development of a general scale. Evaluation and Program Planning. 1979;2:197-207. We focus on the question from that scale that assesses satisfaction with the program. The item asks, "How satisfied are you with the program you have received?" Participants could rank their satisfaction from: 1 = quite dissatisfied, 2 = mildly dissatisfied, 3 = mostly satisfied, 4 = very satisfied." Higher scores correspond with higher satisfaction with the intervention program.

    Time frame: 6 months

  2. Intervention Feasibility

    Feasibility is measured by ability to recruit the planned number of participants into the trial. We wanted to recruit at least 95% of the target number of planned participants. Feasibility is also measured by retention of trial participants at the final timepoint. A cut off of 75% retention of all participants enrolled in the trial at the final timepoint is viewed as a good result for feasibility.

    Time frame: 6 months

  3. Intervention Fidelity

    Fidelity was not based off a published measure. Rather, a neutral observer rated the facilitator's delivery skills and adherence to a manualized protocol for delivering the intervention that guided the consistent delivery of core theoretical components of the intervention. This neutral observer used the following rankings on a scale with rankings ranging from 1 (equating to a category labeled as low demonstration of skills, \<25% of the time) to 3 (equating to a category labeled as high demonstration of skills, \>75% of the time). An average ranking of 2.5 or more is seen as success for fidelity.

    Time frame: From the start of the intervention delivery period to the end of the delivery period - a 2 month timespan in total.

Secondary outcomes

  1. Number of Participants Who Refused Sex at 6 Months

    Measured by comparing whether % of those who refused sex at 6 months versus baseline.

    Time frame: 6 months

  2. Number of Participants Engaging in Intimate Partner Violence at 6 Months

    Measured by examining whether the prevalence of those engaging in intimate partner violence (forced vaginal sex) was significantly lower at 6 months as compared to baseline.

    Time frame: 6 months

  3. Change From Baseline in Likelihood of Bystander Intervention Behavior

    The likelihood of engaging as an active bystander to stop violence is measured through the Bystander Behavior Scale, ranging from 1-40. The questions are answered on a 5-point Likert scale, ranging from 5 = "Very unlikely" to 1 = "Very likely". Lower scores correspond to more likelihood of intervening as an active bystander to stop violence, a measure developed by Miller E, Tancredi DJ, McCauley HL, Decker MR, Virata MCD, Anderson HA, et al. "Coaching Boys into Men": A Cluster-Randomized Controlled Trial of a Dating Violence Prevention Program. Journal of Adolescent Health. 2012;51(5):431-8.

    Time frame: 6 months

06

Results

Posted Jun 24, 2025

Participant flow

Participant flow — Overall Study
MilestoneInterventionControl
Started3030
Completed3030
Not completed00

Outcome measures

PrimaryNumber of Participants With Satisfaction With Intervention Content

Satisfaction with intervention content is based off of a measure called the Client Satisfaction Questionnaire developed by Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: Development of a general scale. Evaluation and Program Planning. 1979;2:197-207. We focus on the question from that scale that assesses satisfaction with the program. The item asks, "How satisfied are you with the program you have received?" Participants could rank their satisfaction from: 1 = quite dissatisfied, 2 = mildly dissatisfied, 3 = mostly satisfied, 4 = very satisfied." Higher scores correspond with higher satisfaction with the intervention program.

Time frame:
6 months
Reported as:
Count of participants · Participants
Number of Participants With Satisfaction With Intervention Content
ParticipantsIntervention
Number of Participants With Satisfaction With Intervention Content28
PrimaryIntervention Feasibility

Feasibility is measured by ability to recruit the planned number of participants into the trial. We wanted to recruit at least 95% of the target number of planned participants. Feasibility is also measured by retention of trial participants at the final timepoint. A cut off of 75% retention of all participants enrolled in the trial at the final timepoint is viewed as a good result for feasibility.

Time frame:
6 months
Reported as:
Count of participants · Participants
Intervention Feasibility
ParticipantsInterventionControl
Intervention Feasibility3030
PrimaryIntervention Fidelity

Fidelity was not based off a published measure. Rather, a neutral observer rated the facilitator's delivery skills and adherence to a manualized protocol for delivering the intervention that guided the consistent delivery of core theoretical components of the intervention. This neutral observer used the following rankings on a scale with rankings ranging from 1 (equating to a category labeled as low demonstration of skills, \<25% of the time) to 3 (equating to a category labeled as high demonstration of skills, \>75% of the time). An average ranking of 2.5 or more is seen as success for fidelity.

Time frame:
From the start of the intervention delivery period to the end of the delivery period - a 2 month timespan in total.
Reported as:
Mean · rankings on a scale ranging from 1 to 3
Intervention Fidelity
rankings on a scale ranging from 1 to 3Intervention
Intervention Fidelity2.75 (1 to 3)
SecondaryNumber of Participants Who Refused Sex at 6 Months

Measured by comparing whether % of those who refused sex at 6 months versus baseline.

Time frame:
6 months
Reported as:
Count of participants · Participants
Number of Participants Who Refused Sex at 6 Months
ParticipantsInterventionControl
Number of Participants Who Refused Sex at 6 Months2424
SecondaryNumber of Participants Engaging in Intimate Partner Violence at 6 Months

Measured by examining whether the prevalence of those engaging in intimate partner violence (forced vaginal sex) was significantly lower at 6 months as compared to baseline.

Time frame:
6 months
Reported as:
Count of participants · Participants
Number of Participants Engaging in Intimate Partner Violence at 6 Months
ParticipantsInterventionControl Arm
Number of Participants Engaging in Intimate Partner Violence at 6 Months04
SecondaryChange From Baseline in Likelihood of Bystander Intervention Behavior

The likelihood of engaging as an active bystander to stop violence is measured through the Bystander Behavior Scale, ranging from 1-40. The questions are answered on a 5-point Likert scale, ranging from 5 = "Very unlikely" to 1 = "Very likely". Lower scores correspond to more likelihood of intervening as an active bystander to stop violence, a measure developed by Miller E, Tancredi DJ, McCauley HL, Decker MR, Virata MCD, Anderson HA, et al. "Coaching Boys into Men": A Cluster-Randomized Controlled Trial of a Dating Violence Prevention Program. Journal of Adolescent Health. 2012;51(5):431-8.

Time frame:
6 months
Reported as:
Mean · score on a scale
Change From Baseline in Likelihood of Bystander Intervention Behavior
score on a scaleInterventionControl
Change From Baseline in Likelihood of Bystander Intervention Behavior27 (1 to 40)30 (1 to 40)

Adverse events

Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention0/30 (0%)0/30 (0%)0/30 (0%)
Control0/30 (0%)0/30 (0%)0/30 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)InterventionControlTotal
<=18 years303060
Between 18 and 65 years000
>=65 years000
Age, Continuous
Age, Continuous(years)InterventionControlTotal
Mean16 (15 to 17)16 (15 to 17)16 (15 to 17)
Sex: Female, Male
Sex: Female, Male(Participants)InterventionControlTotal
Female000
Male303060
Race (NIH/OMB)
Race (NIH/OMB)(Participants)InterventionControlTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American303060
White000
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)InterventionControlTotal
South Africa303060
Intimate Partner Violence (IPV) Behavior
Intimate Partner Violence (IPV) Behavior(Participants)InterventionControlTotal
Count of participants7613
Sexual risk behavior - refusal of sex
Sexual risk behavior - refusal of sex(Participants)InterventionControlTotal
Count of participants171734
Likelhood of Bystander Intervention Behavior
Likelhood of Bystander Intervention Behavior(score on a scale)InterventionControlTotal
Mean29 (25 to 33)31 (28 to 35)30 (25 to 35)
07

Study locations

1 site
  • South African Medical Research School
    Cape Town, South Africa
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Apr 25, 2017
  • Informed consent form · Jan 13, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT03179982
Lead sponsor
Brown University
Collaborators
Medical Research Council, South Africa, Rhode Island Hospital
Responsible party
Caroline Kuo (Assistant Professor, Brown University) — Principal investigator
First posted
Jun 7, 2017
Start date
Feb 1, 2019
Primary completion
Oct 23, 2019
Completion
May 31, 2021
Results posted
Jun 24, 2025
Last update
Jun 24, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion